Avita Medical Inc (RCEL) Stock Price, Quote & News

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices

Sector: Healthcare

Phone: 661 367 9170

Fax: 661 749 9430

Website: avitamedical.com

Address:

28159 Avenue Stanford, Suite 220, Valencia, United States

VALMS Oct. 19 at 9:45 PM

$RCEL ONLY 15 million dollars in cash? New or revised lending covenants with ORBIMED?

1 · Reply

ja1234567 Oct. 18 at 12:26 PM

$RCEL this is actually great for the company. I heard nothing but bad things about the guy. Plus he is obviously bad on strategy. He he only question is whether it’s too late for them,

1 · Reply

JHR Oct. 17 at 5:16 PM

$RCEL

0 · Reply

alexpitti Oct. 17 at 3:36 PM

$RCEL JIM was a liar and a terrible people manager. The problem is it might take until the cms code in 2027 for the business to rebound. The november call won't be good because we will finally hear the truth.

1 · Reply

WorldShakerLuke Oct. 17 at 3:13 PM

$RCEL Have needed a CEO change for quite a while, so this is a good thing. Facts are they are THE game in town for wound treatment and it might take some time, but this is a long term buy and hold. I bought another 2500 shares, now holding 15k at $4.55

0 · Reply

JarvisFlow Oct. 17 at 3:07 PM

Lake Street has updated their rating for AVITA Medical ( $RCEL ) to Hold with a price target of 4.

0 · Reply

topstockalerts Oct. 17 at 2:00 PM

Avita Medical Ltd's stock fell 21.9% pre-market on Friday following an immediate leadership change and board restructuring. The company named Cary Vance as interim CEO, replacing Jim Corbett, who also stepped down from the board. Vance will remain as Chairman and Jan Stern Reed was appointed Lead Independent Director. Avita plans to hire an executive search firm to find a permanent CEO, considering both internal and external candidates. BTIG analyst Ryan Zimmerman, who maintains a Sell rating and a $3.00 price target, commented that the leadership changes might bring temporary instability to the company. $RCEL

0 · Reply

Bruces4 Oct. 17 at 1:09 PM

$RCEL Short interest WAY DOWN past 30 days to 3.3M now. Lots covered on the God CANDLE on 19M shares the day of the European approval PR. Another big chunk will cover today with all the negative news behind us. Onward and upward from here - regardless the CHRONIC DESPERATE postings of the panicked shorts.

0 · Reply

healthcareguru Oct. 17 at 12:58 PM

$RCEL don’t forget: they’re still out of cash!!!! PURE TRASH & NO CASH. $0 PT. 🐺👎

0 · Reply

UgoGreg Oct. 17 at 12:48 PM

$RCEL https://youtu.be/DTJiFOQEvN4

0 · Reply

AVITA Medical Announces CEO Transition

Oct 16, 2025, 5:43 PM EDT - 8 days ago

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Oct 9, 2025, 12:49 PM EDT - 16 days ago

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Oct 1, 2025, 8:30 AM EDT - 24 days ago

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Sep 18, 2025, 7:30 AM EDT - 5 weeks ago

AVITA Medical: Reimbursement Reset And Breakeven Path By 2026

Sep 11, 2025, 3:31 PM EDT - 6 weeks ago

RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm

Sep 9, 2025, 3:47 PM EDT - 6 weeks ago

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sep 8, 2025, 6:23 PM EDT - 6 weeks ago

AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Aug 21, 2025, 4:05 PM EDT - 2 months ago

AVITA Medical Announces September Investor Conference Participation

Aug 12, 2025, 8:30 AM EDT - 2 months ago

AVITA Medical Successfully Completes Australian Equity Raise

Aug 10, 2025, 7:00 PM EDT - 2 months ago

AVITA Medical to Host Investor Webinar Briefing

Aug 8, 2025, 3:21 PM EDT - 2 months ago

AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 2 months ago

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

Jul 28, 2025, 4:05 PM EDT - 3 months ago

AVITA Medical to Announce Second Quarter 2025 Financial Results

Jun 3, 2025, 8:00 PM EDT - 5 months ago

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

May 8, 2025, 9:50 PM EDT - 6 months ago

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:03 PM EDT - 6 months ago

AVITA Medical Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 6 months ago

AVITA Medical to Announce First Quarter 2025 Financial Results

Apr 9, 2025, 4:05 PM EDT - 7 months ago

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

Apr 3, 2025, 4:03 PM EDT - 7 months ago

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

Mar 17, 2025, 4:05 PM EDT - 7 months ago

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

Feb 26, 2025, 5:30 PM EST - 8 months ago

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

Feb 18, 2025, 12:01 PM EST - 8 months ago

After Sales Rebound In January, AVITA Is Set Up For A Monster Year

Feb 13, 2025, 9:33 PM EST - 9 months ago

AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 4:01 PM EST - 9 months ago

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 12, 2025, 10:52 PM EST - 10 months ago

Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish

Jan 10, 2025, 6:28 PM EST - 10 months ago

AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini

Jan 8, 2025, 1:06 PM EST - 10 months ago

Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals

Jan 8, 2025, 8:14 AM EST - 10 months ago

AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 7, 2025, 10:12 PM EST - 10 months ago

AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 4:35 PM EST - 10 months ago

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

Jan 2, 2025, 11:26 AM EST - 10 months ago

AVITA Medical Just Tripled Its TAM In The Burn Market

Dec 23, 2024, 4:02 PM EST - 10 months ago

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

Dec 19, 2024, 5:05 PM EST - 11 months ago

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

Dec 18, 2024, 4:08 PM EST - 11 months ago

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 25, 2024, 4:02 PM EST - 11 months ago

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

Nov 12, 2024, 4:03 PM EST - 1 year ago

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

Nov 9, 2024, 6:39 AM EST - 1 year ago

AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:03 PM EST - 1 year ago

AVITA Medical Reports Third Quarter Financial Results

Oct 10, 2024, 5:15 PM EDT - 1 year ago

AVITA Medical to Announce Third Quarter 2024 Financial Results

Oct 2, 2024, 1:07 PM EDT - 1 year ago

AVITA Medical Headed For Its Most Important Report, I'm Extremely Bullish

Sep 12, 2024, 4:05 PM EDT - 1 year ago

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

Sep 10, 2024, 4:03 PM EDT - 1 year ago

AVITA Medical to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference

VALMS Oct. 19 at 9:45 PM

$RCEL ONLY 15 million dollars in cash? New or revised lending covenants with ORBIMED?

1 · Reply

ja1234567 Oct. 18 at 12:26 PM

$RCEL this is actually great for the company. I heard nothing but bad things about the guy. Plus he is obviously bad on strategy. He he only question is whether it’s too late for them,

1 · Reply

JHR Oct. 17 at 5:16 PM

$RCEL

0 · Reply

alexpitti Oct. 17 at 3:36 PM

1 · Reply

WorldShakerLuke Oct. 17 at 3:13 PM

0 · Reply

JarvisFlow Oct. 17 at 3:07 PM

Lake Street has updated their rating for AVITA Medical ( $RCEL ) to Hold with a price target of 4.

0 · Reply

topstockalerts Oct. 17 at 2:00 PM

0 · Reply

Bruces4 Oct. 17 at 1:09 PM

0 · Reply

healthcareguru Oct. 17 at 12:58 PM

$RCEL don’t forget: they’re still out of cash!!!! PURE TRASH & NO CASH. $0 PT. 🐺👎

0 · Reply

UgoGreg Oct. 17 at 12:48 PM

$RCEL https://youtu.be/DTJiFOQEvN4

0 · Reply

healthcareguru Oct. 17 at 12:47 PM

$RCEL and the downgrades begin…still have to annihilate guidance and bankruptcy pending. Delisting in clear focus. Any fake bull here clearly can’t read or do math. GAME OVER. It’s a ZERO. 🐺👎

0 · Reply

healthcareguru Oct. 17 at 12:45 PM

$RCEL EPIC DISASTER…see you at $0. I warned you. 🐺👎

0 · Reply

OpenOutcrier Oct. 17 at 12:17 PM

$RCEL (-24.5% pre) AVITA Medical Announces CEO Transition https://ooc.bz/l/80978

0 · Reply

JarvisFlow Oct. 17 at 11:42 AM

D. Boral Capital updates rating for AVITA Medical ( $RCEL ) to Buy, target set at 14.

1 · Reply

Arcides Oct. 17 at 10:52 AM

$RCEL that 3.6 low is waiting for this...

1 · Reply

healthcareguru Oct. 17 at 1:40 AM

$RCEL WHAT DID I SAY?!?!? CEO = shitcanned; 3Q sales preannounced ~30% BELOW Street estimates; 2025 guidance getting slashed. BANKRUPTCY is IMMINENT. Proof they are further violating debt covenants. This will be down 75%+ FAST… $0 PT. 😂😂😂😂😂😂😂😂😂😂😂😂🐺🐺🐺🐺🐺👎👎👎👎👎 $XBI $IWM $IHI

0 · Reply

BioGem Oct. 17 at 1:12 AM

$RCEL This news confirms that this company is a fiasco, revenue projection for Q3 is horrible, cash will evaporate, while large debt covenants again broken. This should be quite shortable at the open tomorrow.

1 · Reply

Wats_Up Oct. 16 at 11:20 PM

$RCEL Kind of surprised by the afterhours drop. This sure sounds like good news to me.

0 · Reply

Wats_Up Oct. 16 at 11:15 PM

$RCEL The Company expects preliminary revenue for the third quarter ended September 30, 2025, to be approximately $17 million. No wonder there has been a change.

0 · Reply

Wats_Up Oct. 16 at 11:12 PM

$RCEL

0 · Reply

Wats_Up Oct. 16 at 11:11 PM

$RCEL Wow! AVITA Medical", or the "Company"), a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Mr. Vance will continue to serve as Chairman of the Board, while Board member Jan Stern Reed has been appointed Lead Independent Director. The Board intends to engage an executive search firm to assist with selecting a permanent CEO. This process will include a mix of internal and external candidates, including Mr. Vance.

0 · Reply

Fmello Oct. 10 at 9:18 PM

$RCEL https://spectrumnews1.com/oh/columbus/news/2025/08/11/advanced-technology-decreases-recovery-time-for-burn-survivors

0 · Reply

Market Cap	107.01M
Revenue (ttm)	64.25M
Net Income (ttm)	-61.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-96.26%
Debt to Equity Ratio	-3.28

Volume	160,900
Avg Vol	702,070
Day's Range	N/A - N/A
Shares Out	26.62M
Stochastic %K	8%
Beta	1.64
Analysts	Sell
Price Target	$7.50